176 related articles for article (PubMed ID: 22142160)
21. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
Soars MG; Webborn PJ; Riley RJ
Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
[TBL] [Abstract][Full Text] [Related]
22. Implications of the dominant role of transporters in drug uptake by cells.
Dobson PD; Lanthaler K; Oliver SG; Kell DB
Curr Top Med Chem; 2009; 9(2):163-81. PubMed ID: 19200003
[TBL] [Abstract][Full Text] [Related]
23. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
Feng B; LaPerle JL; Chang G; Varma MV
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of ethnic differences in drug disposition and response.
Xie HG; Kim RB; Wood AJ; Stein CM
Annu Rev Pharmacol Toxicol; 2001; 41():815-50. PubMed ID: 11264478
[TBL] [Abstract][Full Text] [Related]
25. Drug disposition in pathophysiological conditions.
Gandhi A; Moorthy B; Ghose R
Curr Drug Metab; 2012 Nov; 13(9):1327-44. PubMed ID: 22746301
[TBL] [Abstract][Full Text] [Related]
26. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
[TBL] [Abstract][Full Text] [Related]
27. Quantitative PCR analysis and protein distribution of drug transporter genes in the rat cochlea.
Manohar S; Jamesdaniel S; Ding D; Salvi R; Seigel GM; Roth JA
Hear Res; 2016 Feb; 332():46-54. PubMed ID: 26626361
[TBL] [Abstract][Full Text] [Related]
28. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.
Zolk O; Fromm MF
Clin Pharmacol Ther; 2011 Jun; 89(6):798-805. PubMed ID: 21471963
[TBL] [Abstract][Full Text] [Related]
29. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition.
Bleasby K; Castle JC; Roberts CJ; Cheng C; Bailey WJ; Sina JF; Kulkarni AV; Hafey MJ; Evers R; Johnson JM; Ulrich RG; Slatter JG
Xenobiotica; 2006; 36(10-11):963-88. PubMed ID: 17118916
[TBL] [Abstract][Full Text] [Related]
30. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
Rodieux F; Gotta V; Pfister M; van den Anker JN
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
[TBL] [Abstract][Full Text] [Related]
31. [Molecular mechanisms of drug transport].
Endou H
Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):114-24. PubMed ID: 11031740
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in the membrane transport of endogenous and exogenous compounds.
Morris ME; Lee HJ; Predko LM
Pharmacol Rev; 2003 Jun; 55(2):229-40. PubMed ID: 12773628
[TBL] [Abstract][Full Text] [Related]
33. Drug transporters and imatinib treatment: implications for clinical practice.
Eechoute K; Sparreboom A; Burger H; Franke RM; Schiavon G; Verweij J; Loos WJ; Wiemer EA; Mathijssen RH
Clin Cancer Res; 2011 Feb; 17(3):406-15. PubMed ID: 21163869
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
[TBL] [Abstract][Full Text] [Related]
35. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
Brouwer KL; Aleksunes LM; Brandys B; Giacoia GP; Knipp G; Lukacova V; Meibohm B; Nigam SK; Rieder M; de Wildt SN;
Clin Pharmacol Ther; 2015 Sep; 98(3):266-87. PubMed ID: 26088472
[TBL] [Abstract][Full Text] [Related]
36. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.
Zhang T; Xiang CD; Gale D; Carreiro S; Wu EY; Zhang EY
Drug Metab Dispos; 2008 Jul; 36(7):1300-7. PubMed ID: 18411399
[TBL] [Abstract][Full Text] [Related]
37. Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays.
Anderle P; Huang Y; Sadée W
Eur J Pharm Sci; 2004 Jan; 21(1):17-24. PubMed ID: 14706809
[TBL] [Abstract][Full Text] [Related]
38. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.
Wu KC; Lin CJ
J Food Drug Anal; 2019 Jan; 27(1):48-59. PubMed ID: 30648594
[TBL] [Abstract][Full Text] [Related]
39. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson PD; Kell DB
Nat Rev Drug Discov; 2008 Mar; 7(3):205-20. PubMed ID: 18309312
[TBL] [Abstract][Full Text] [Related]
40. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
Elmorsi Y; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
